Paper30697281
A Review of Driver Genetic Alterations in Thyroid Cancers.
Khatami F and 1 other. Iran J Pathol, 2018. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. A Review of Driver Genetic Alterations in Thyroid Cancers. Papers, record 30697281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30697281
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10566678 | High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. | J Clin Endocrinol Metab | 1999 | https://conductscience.org/library/papers/10566678 | PubMed |
| 2 | 10647931 | The hallmarks of cancer. | Cell | 2000 | https://conductscience.org/library/papers/10647931 | PubMed |
| 3 | 10698491 | RAS oncogene activation induces proliferation in normal human thyroid epithelial cells without loss of differentiation. | Oncogene | 2000 | https://conductscience.org/library/papers/10698491 | PubMed |
| 4 | 10720057 | The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults. | J Clin Endocrinol Metab | 2000 | https://conductscience.org/library/papers/10720057 | PubMed |
| 5 | 10946873 | Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia. | J Clin Endocrinol Metab | 2000 | https://conductscience.org/library/papers/10946873 | PubMed |
| 6 | 11238046 | Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. | Am J Pathol | 2001 | https://conductscience.org/library/papers/11238046 | PubMed |
| 7 | 11445581 | Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11445581 | PubMed |
| 8 | 11493988 | ret/PTC-1 Activation in Hashimoto Thyroiditis. | Int J Surg Pathol | 2000 | https://conductscience.org/library/papers/11493988 | PubMed |
| 9 | 11707626 | RET oncogene activation in papillary thyroid carcinoma. | Adv Anat Pathol | 2001 | https://conductscience.org/library/papers/11707626 | PubMed |
| 10 | 12114746 | RET/PTC rearrangement in thyroid tumors. | Endocr Pathol | 2002 | https://conductscience.org/library/papers/12114746 | PubMed |
| 11 | 12603533 | Lower esophagus in dyspeptic Iranian patients: a prospective study. | J Gastroenterol Hepatol | 2003 | https://conductscience.org/library/papers/12603533 | PubMed |
| 12 | 12670889 | High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. | Cancer Res | 2003 | https://conductscience.org/library/papers/12670889 | PubMed |
| 13 | 12697856 | BRAF mutation in papillary thyroid carcinoma. | J Natl Cancer Inst | 2003 | https://conductscience.org/library/papers/12697856 | PubMed |
| 14 | 12720532 | Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. | Eur J Endocrinol | 2003 | https://conductscience.org/library/papers/12720532 | PubMed |
| 15 | 12881714 | BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. | Oncogene | 2003 | https://conductscience.org/library/papers/12881714 | PubMed |
| 16 | 12970315 | Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. | J Clin Endocrinol Metab | 2003 | https://conductscience.org/library/papers/12970315 | PubMed |
| 17 | 14739493 | Comparison of fine-needle-nonaspiration with fine-needle-aspiration technique in the cytologic studies of thyroid nodules. | Endocr Pathol | 2003 | https://conductscience.org/library/papers/14739493 | PubMed |
| 18 | 15075002 | Epidemiologic analysis of the Tehran Cancer Institute Data System Registry (TCIDSR). | Asian Pac J Cancer Prev | 2004 | https://conductscience.org/library/papers/15075002 | PubMed |
| 19 | 15356021 | Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. | J Clin Endocrinol Metab | 2004 | https://conductscience.org/library/papers/15356021 | PubMed |
| 20 | 15502856 | Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma. | Lab Invest | 2004 | https://conductscience.org/library/papers/15502856 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41303583 | Inside the Matrix: Integrated Cytology and Molecular Testing of Thyroid FNAC Samples Using a Commercial Synthetic 3D Scaffold. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303583 | PubMed |
| 40407962 | Dual roles of long non-coding RNAs in thyroid cancer: regulation of programmed cell death pathways. | Med Oncol | 2025 | https://conductscience.org/library/papers/40407962 | PubMed |
| 39610531 | Thyroid Cancer research at endocrinology and metabolism research institute (EMRI): a report of scientific activities between 2005 and 2020. | J Diabetes Metab Disord | 2024 | https://conductscience.org/library/papers/39610531 | PubMed |
| 38785786 | Long Non-Coding RNAs as Determinants of Thyroid Cancer Phenotypes: Investigating Differential Gene Expression Patterns and Novel Biomarker Discovery. | Biology (Basel) | 2024 | https://conductscience.org/library/papers/38785786 | PubMed |
| 38022847 | Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review). | Mol Clin Oncol | 2023 | https://conductscience.org/library/papers/38022847 | PubMed |
| 36733350 | Identification of KIT and BRAF mutations in thyroid tissue using next-generation sequencing in an Ecuadorian patient: A case report. | Front Oncol | 2022 | https://conductscience.org/library/papers/36733350 | PubMed |
| 36605433 | Molecular features of aggressive thyroid cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/36605433 | PubMed |
| 36202607 | Use of multikinase inhibitors/lenvatinib in patients with synchronous/metachronous cancers coinciding with radioactive-resistant differentiated thyroid cancer. | Cancer Med | 2022 | https://conductscience.org/library/papers/36202607 | PubMed |
| 35630083 | Sorafenib in Metastatic Papillary Thyroid Carcinoma with BRAF K601E Mutation on Liquid Biopsy: A Case Report and Literature Review. | Medicina (Kaunas) | 2022 | https://conductscience.org/library/papers/35630083 | PubMed |
| 34684168 | Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers. | Medicina (Kaunas) | 2021 | https://conductscience.org/library/papers/34684168 | PubMed |
| 34680260 | PPARγ Targets-Derived Diagnostic and Prognostic Index for Papillary Thyroid Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34680260 | PubMed |
| 33889297 | Analytic validation and clinical utilization of the comprehensive genomic profiling test, GEM ExTra®. | Oncotarget | 2021 | https://conductscience.org/library/papers/33889297 | PubMed |
| 32751138 | Novel Targeted Therapies for Metastatic Thyroid Cancer-A Comprehensive Review. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32751138 | PubMed |
| 32351906 | Liquid Biopsy as a Minimally Invasive Source of Thyroid Cancer Genetic and Epigenetic Alterations. | Int J Mol Cell Med | 2019 | https://conductscience.org/library/papers/32351906 | PubMed |
| 32260561 | Current Insights into Combination Therapies with MAPK Inhibitors and Immune Checkpoint Blockade. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32260561 | PubMed |
| 32064050 | Tumor suppressor genes and allele-specific expression: mechanisms and significance. | Oncotarget | 2020 | https://conductscience.org/library/papers/32064050 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30697281
GET https://conductscience.org/api/papers/v1/30697281/references?page=2